Fu, An
Ge, Feng
Wang, Yanwei
Guo, Haili
Zhu, Man
Li, Shu
Gao, Ao
Li, Chao
Lu, Jingchuan
Guo, Daihong
Funding for this research was provided by:
a confidential project (17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010, 17CXZ010)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03, Y2023FH-YWPJ03)
Article History
Received: 31 July 2023
Accepted: 24 June 2024
First Online: 12 July 2024
Declarations
:
: This study involving humans was approved by the Ethics Committee of Chinese PLA General Hospital with a waiver of the requirement for informed consent (S2018-054-01).
: Not applicable.
: The authors declare no competing interests.